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Abstract
Aims/hypothesis Fractal analysis of the retinal vasculature
provides a global measure of the complexity and density of
retinal vessels summarised as a single variable: the fractal
dimension. We investigated fractal dimensions as long-term
predictors of microvasculopathy in type 1 diabetes.
Methods We included 180 patients with type 1 diabetes in a
16 year follow-up study. In baseline retinal photographs (from
1995), all vessels in a zone 0.5–2.0 disc diameters from the
disc margin were traced using Singapore Institute Vessel
Assessment-Fractal image analysis software. Artefacts were
removed by a certified grader, and fractal dimensions were
calculated using the box-counting method. At follow-up (in
2011), diabetic neuropathy, nephropathy and proliferative
retinopathy were assessed and related to baseline fractal
dimensions in multiple regressions adjusted for sex and
baseline age, diabetes duration, HbA1c, BP, BMI, vibration
perception threshold, albuminuria, retinopathy and vessel
diameters.
Results Mean baseline age and diabetes duration were 21.0
and 13.4 years, respectively, and of patients 50.0% were
males. The mean fractal dimension was 1.3817. The 16 year
incidences of neuropathy, nephropathy and proliferative reti-
nopathy were 10.8%, 8.0% and 27.9%, respectively. Multiple
regression analyses showed a lower fractal dimension to sig-
nificantly predict incident neuropathy (OR 1.17 per 0.01
fractal dimension decrease [95% CI 1.01, 1.36]), nephropathy
(OR 1.40 per 0.01 fractal dimension decrease [95% CI 1.10,
1.79]) and proliferative retinopathy (OR 1.22 per 0.01 fractal
dimension decrease [95% CI 1.09, 1.37]).
Conclusions/interpretation The retinal vascular fractal di-
mension is a shared biomarker of diabetic microvasculopathy,
thus indicating a possible common pathogenic pathway.
Retinal fractal analysis therefore is a potential tool for risk
stratification in type 1 diabetes.
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Introduction
Microvascular complications remain common in type 1 dia-
betes [1, 2]. Identifying early biomarkers of diabetic periph-
eral neuropathy (DPN), diabetic nephropathy (DN) and dia-
betic retinopathy (DR) will allow the earlier implementation
of treatment and support the development of new treatment
modalities.
Measurements of vessel calibres in retinal photos could
potentially deliver such biomarkers [3–7], but more global
variables are available, for example retinal vascular fractal
dimensions. The fractal dimension summarises the complex-
ity and density of branching structures characterised by self-
similarity and a similar level of complexity despite changes in
magnification (for example snowflakes, tree branches, light-
ning). Correspondingly, the retinal vascular tree has features
of a fractal [8]. The fractal dimension increases with increas-
ing structural complexity.
Few studies on retinal vascular fractal dimensions and
microvascular complications have been performed. Higher
fractal dimensions have been linked to early signs of DR [9]
and proliferative diabetic retinopathy (PDR) [10]. However,
one study reported lower fractal dimensions in patients with
PDR after pan-retinal photocoagulation and in patients with
DPN, while a trend towards associations with DN was seen
[11]. The latter observation is supported by a study examining
the likelihood of microalbuminuria in DN [12]. All studies
were of cross-sectional design.
Only a single prospective study exists. This study exam-
ined retinal vascular fractal dimensions and incident DR [13].
However, the follow-up period was short (mean 2.9 years) and
incident cases had mild non-proliferative DR. Thus, the pre-
dictive value of fractal dimensions on severe DR remains
unknown.
We carried out a prospective study to examine whether
retinal vascular fractal dimensions can predict long-term mi-
crovascular complications in type 1 diabetes. We aimed to
investigate the predictive value of retinal vascular fractal
dimensions on the 16 year incidence of DPN, DN and PDR
in a young population-based Danish cohort.
Methods
Study population This study formed part of a paediatric co-
hort study of Danish children with type 1 diabetes, initiated in
1987–1989 (n=720): the Danish Cohort of Pediatric Diabetes
1987. Clinical characteristics of this cohort have been reported
elsewhere [14–17]. Of this cohort, 339 participants were in-
cluded in a baseline examination in 1995, where they also had
fundus photographs taken. These 339 participants were thus
eligible for 16 year follow-up in 2011 and for fractal analysis.
Of these, 15 (4.4%) were excluded from follow-up because of
missing baseline retinal photographs, 13 (3.8%) had died and
63 (18.6%) were unreachable because they had emigrated or
could not be contacted owing to research protection.
Of the remaining 248 patients, 185 (74.6%) participated in
follow-up in 2011 and 63 (25.4%) declined to take part. A
dropout analysis of the reduction in the cohort from 1995 to
2011 was described previously [14]. In brief, the 185 partic-
ipants at follow-up had significantly lower levels of HbA1c,
higher values of vibration perception threshold (VPT) and
were older than the ones who dropped out. The groups did
not differ in terms of sex, age at onset, diabetes duration, BP,
BMI, presence of albuminuria, or level of DR at baseline.
The study was performed in accordance with the criteria of
the Helsinki II Declaration and was approved by the local
scientific ethics committee. All patients gave written informed
consent at both baseline and follow-up examinations.
Baseline examinations and measurements of the retinal
vascular fractal dimension In 1995, participants underwent
an interview in which information on sex, age and diabetes
duration was obtained. Further, data on BP, BMI, HbA1c, mean
albumin excretion rate (AER) and VPT were assessed using
previously described methods [15]. Baseline micro- and
macroalbuminuria were defined as mean AERs of
20–200 μg/min and >200 μg/min, respectively, in at least
two timed overnight urine samples. After pupillary dilation,
colour retinal photographs were taken with 40°–60° retinal
cameras, in accordance with European Diabetes Study Group
(EURODIAB) recommendations [18]. Film slides were later
digitalised using a DigitDia 5000 Filmscanner (Reflecta,
Rottenburg, Germany). The disc–nasal field of the right eye
was used for analyses of retinal vascular fractal dimensions. If
the image of the right eyewas ungradable, then the left eye was
used for the analyses.
For the assessment of baseline DR and to rule out PDR, all
photos were graded by the same certified grader using a
modified Early Treatment of Diabetic Retinopathy Study
(ETDRS) protocol and allowing for non-standard photogra-
phy in 1995, as previously described [14].
A semiautomated computer program was used to assess the
retinal vascular fractal dimension (Singapore Institute Vessel
Assessment-Fractal version 1.0, School of Computing, Na-
tional University of Singapore, Singapore) by a standardised
protocol. The optic disc was automatically detected by the
software, all vessels were identified and those coursing
through a zone 0.5–2.0 disc diameters from the disc margin
were used for the analyses. The program provided
skeletonised line tracing of the vasculature and, by comparing
this to the original retinal colour image, any artefacts
misidentified as vessels were removed by a certified grader.
Examples of artefacts erroneously included in the line tracing
are choroid vessels, pigment abnormalities and photograph
halos. The retinal vascular fractal dimension was calculated
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from the refined line tracing by the box-counting method of
the program, an established method for structures that are not
perfectly self-similar, such as the retinal vasculature [19–21].
Figure 1 shows examples of retinal colour images and the
corresponding refined line tracing for two of the participants
in this study. The average time used for fractal analysis of each
image in this study was 10 min.
The image used for fractal analysis was further analysed
using different image analysis software (IVAN, Department of
Ophthalmology Visual Science, University of Wisconsin,
Madison,WI, USA) to assess the retinal arteriolar and venular
calibres. These were summarised using the ‘Big-6 formula’
into the central retinal arteriolar equivalent (CRAE) and cen-
tral retinal venular equivalent (CRVE), respectively [22].
Outcome measures in 2011 Participants underwent examina-
tions between 1 January and 1 November 2011. DPN was
assessed with a hand-held biothesiometer (Bio-Medical
Instrument, Newbury, OH, USA). Three measurements on
the apex of the right first toe were made and the VPT was
calculated as the mean of the last two. Participants with a VPT
of >25 V were classified as having DPN.
At follow-up, all participants were asked to hand in spot
urine samples unless they were menstruating or had ongoing
infections; in those circumstances, they were asked to hand in
samples at a later time. A spot urine albumin:creatinine ratio
(ACR) was calculated from albumin and creatinine analyses
performed on an Abbott Architect analyzer (Abbott,
Deerfield, IL, USA) using immunoturbidimetric and enzymat-
ic assays, respectively. Participants with macroalbuminuria
(ACR ≥300 mg/g), with a history of kidney transplantation
or who had received dialysis were all classified as having DN.
Participants had mydriatic colour retinal photographs taken
by the same trained and certified operator using a 3D
OCT-2000 Spectral Domain optical coherence tomography
system (Topcon, Tokyo, Japan). Seven 45° fields were taken
for each eye, in accordance with ETDRS standards [23]. A
modified ETDRS scale was used for assessment of PDR, as
previously described [14]. Participants with ETDRS levels of
61 or above in the eye included in the fractal analyses were
classified as having PDR.
Statistical methods Categorical data are presented as percent-
ages, and continuous data are presented as means ± SD. We
used the Mann–Whitney U test to assess differences between
two groups, Cuzick’s test to identify trends among several
groups and the Spearman rank correlation to test for associa-
tions between continuous variables. Multiple logistic regres-
sion analyses with backwards selection were performed to
estimate ORs for incident DPN, DN and PDR. Models were
adjusted for sex and baseline age, diabetes duration, HbA1c,
systolic and diastolic BP, BMI, VPT, mean AER, level of
retinopathy, CRAE, and CRVE.
All participants with a VPT of <25 V at baseline were
considered at risk of incident DPN, and all participants with-
out PDR at baseline were considered at risk of incident PDR.
Patients with a baseline meanAER of >200μg/min (indicating
overt DN) were excluded from renal function analyses at
follow-up.
For estimates of ORs, 95% CIs were considered sta-
tistically significant when they did not cross 1.0. Findings
with a p value of <0.05 were considered statistically
significant.
All statistical calculations were performed using Stata 11.1
(StataCorp, College Station, TX, USA).
Results
Study population characteristics Of the 185 participants, frac-
tal analysis was not possible in either eye of five patients
(2.7%) because more than 25% of the vessels were untrace-
able within the predefined grid, in accordance with the
standardised protocol. No significant differences in baseline
characteristics between participants with and without gradable
photos were found with respect to sex, baseline age, diabetes
duration, HbA1c, BP, BMI, VPT, mean AER and level of
Fig. 1 Line tracings and zones. The retinal vascular fractal dimension is
calculated from the line tracing in the marked zone 0.5–2.0 disc diameters
(DD) from the disc margin; magnification ×1.84. The disc diameter is
1,800 μm in humans. (a) Cropped retinal image and line tracing of an eye
in the tenth percentile with a fractal dimension of 1.3180 and a less
complex vascular pattern. At follow-up, this participant had developed
peripheral neuropathy, nephropathy and proliferative retinopathy. (b)
Cropped retinal image and line tracing of an eye in the 90th percentile
with a fractal dimension of 1.4678 and a more complex vascular pattern.
At follow-up, this participant had neither peripheral neuropathy, nephrop-
athy nor proliferative retinopathy
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retinopathy (data not shown). None of the five participants
with non-gradable baseline photos for retinal vascular fractals
had developed DPN, DN or PDR at follow-up.
A total of 180 patients with at least one gradable photo were
included in the remaining analyses. For those participants, mean
age and diabetes duration at baseline were 21.0 and 13.4 years,
respectively, and 50.0% were males. The mean retinal vascular
fractal dimension was 1.3817 (range 1.1932–1.5164).
Relationship between retinal vascular fractal dimension and
clinical baseline characteristics Table 1 shows that a lower
retinal fractal dimension was significantly related to higher
levels of both albuminuria and retinopathy at baseline, while
there were no differences in fractal dimensions between males
and females. When testing for rank correlations between
retinal vascular fractal dimensions and the remaining baseline
variables (i.e. age, diabetes duration, HbA1c, systolic and
diastolic BP, BMI, VPT, CRAE and CRVE), no significant
associations were found (data not shown).
Associations between retinal vascular calibres and incident
DPN DPN was evaluated at follow-up in 157 patients who
had a VPT of <25 Vat baseline in 1995 and gradable baseline
photos. Of these, 10.8% (n=17) had developed DPN in the
intervening 16 years.
As seen in Table 2, a lower retinal vascular fractal dimen-
sion was significantly associated with incident DPN (OR 1.17
per 0.01 decrease in fractal dimension [95% CI 1.01, 1.36]) in
the full multiple logistic regression model adjusted for sex and
baseline age, diabetes duration, HbA1c, BP, BMI, VPT, mean
AER, level of retinopathy, CRAE and CRVE. The same
association was seen in models after adjusting for fewer
baseline variables.
Associations of retinal vascular calibres and DN A total of
163 participants with gradable baseline photos and no
macroalbuminuria in 1995 handed in urine samples at
follow-up. Of these, 8.0% (n=13) had developed
macroalbuminuria by 2011, had had a kidney transplant or
had received dialysis by the time of follow-up.
A lower fractal dimensionwas significantly associatedwith
the 16 year incidence of DN in all multiple logistic regression
analyses carried out for this outcome, as seen in Table 2 (OR
1.40 per 0.01 decrease in fractal dimension in the full model
[95% CI 1.10, 1.79]).
Associations between retinal vascular calibres and incident
PDR Of the 180 participants with gradable baseline photos,
one had PDR in 1995 and was therefore excluded from this
analysis. Of the 179 patients at risk, 27.9% (n=50) progressed
to PDR on the eye chosen for vessel analyses during the
16 year period. As shown in Table 2, the full multiple logistic
regression found lower retinal vascular fractal dimension to be
significantly associated with the 16 year incidence of PDR
(OR 1.22 per 0.01 decrease in fractal dimension [95%CI 1.09,
1.37]), when adjusting for sex and baseline age, diabetes
duration, HbA1c, BP, BMI, VPT, mean AER, level of retinop-
athy, CRAE and CRVE. The same association was seen in
models that adjusted for fewer baseline variables.
Discussion
A lower retinal vascular fractal dimension was consistently
associated with the 16 year incidence of DPN, DN and PDR in
this prospective study of young Danish patients with type 1
diabetes. It was also associated with higher levels of albumin-
uria and retinopathy at baseline. These findings are consistent
with existing cross-sectional studies [11, 12], but not with the
single prospective report on incident retinopathy prediction
[13]. However, for the latter study, the follow-up period was
relatively short (mean 2.9 years) and all incident cases had
mild retinopathy (ETDRS of ≤31). Therefore, no conclusions
can be made on whether the retinal vascular fractal dimension
can predict more severe levels of DR based on this study.
Furthermore, the dynamic nature of DR creates misclassifica-
tion issues because it is common for a patient to have minor
signs of DR (ETDRS of ≤31) at one examination and none at
the next, and vice versa.
The pathophysiological mechanisms underlying the find-
ings in the present study are unclear, but endothelial dysfunc-
tion has previously been speculated to be the common link
Table 1 Baseline characteristics (1995) in relation to the retinal vascular
fractal dimension for 180 participants from the DCPD1987 study
Clinical characteristic Retinal fractal dimension
n Mean±SD p valuea
Sex
Male 90 1.3807±0.061 0.90
Female 90 1.3828±0.049
Albuminuria
None 149 1.3866±0.052 <0.01
Micro 13 1.3473±0.059
Macro 5 1.3277±0.096
Retinopathy
ETDRS 10 84 1.3913±0.052 <0.04
ETDRS 20 65 1.3790±0.055
ETDRS 35 29 1.3691±0.063
ETDRS 43 6 1.3399±0.044
ETDRS 65 1 1.3693
Data are means±SD
aMann–Whitney U tests were used for comparison between two groups,
and Cuzick’s tests were used for comparison between several groups
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between microvascular complications in type 1 diabetes [24].
Several endothelium-generated vasoconstrictors are produced
in abnormally high amounts in diabetes, the main one being
endothelin-1 [25]. At the same time, impaired production of
nitric oxide (a vasodilator) is observed in endothelial dysfunc-
tion [26]. Vasoconstriction may therefore contribute to the
lower vessel density seen in our study. However, in early
uncomplicated diabetes, both small and large blood vessels
have been shown to dilate, not contract [27]. Nonetheless,
dilation will increase blood flow and cause capillary hyper-
tension, which will damage the endothelium over time. At this
stage, impaired endothelium-dependent vasodilation can oc-
cur, thus reducing blood flow and leading to hypoxia. We
therefore speculate that a lower fractal dimension of the retinal
vasculature may be linked to vasoconstriction induced by
endothelial dysfunction.
The autoregulatory response in the retinal vasculature is
impaired in patients with diabetes and no retinopathy, and
becomes progressively more impaired with increasing levels
of retinopathy [28]. Thus, collateral formation in response to
hypoxia may be altered, leading to a less complex vasculature
than is normally required for optimal oxygenation. As the
renal vasculature exhibits similar autoregulation, we speculate
that this is likely to occur in the kidneys.
Genetics provides another perspective to these findings. It
was previously suggested that subsets of patients with type 1
diabetes may have a genetic predisposition towards
microvasculopathy because not all patients with high glucose
levels develop complications [29]. Additionally, some patients
develop complications despite having only slightly elevated
glucose levels [30]. A less complex branching pattern of the
microvasculature may provide a limited facility to form col-
laterals when metabolic demand exceeds the current oxygen
supply, which will lead to hypoxia.
Studies have shown a reduction in the retinal fractal dimen-
sion with age [11, 31, 32]. If this represents a more general
phenomenon for the systemic microvasculature, then some
patients could be more prone to hypoxia-induced organ dam-
age over time, simply as a result of suboptimal vascular
geometry being already in place at diabetes onset.
In this study, a rather high incidence of PDRwas seen. This
was previously discussed in detail in another report [14]
but, in brief, a high level of HbA1c at baseline (mean HbA1c
9.5%±1.6% [81±17 mmol/mol]) in 1995) was believed to be
the main cause.
Major strengths of this study are the population-based
design, long follow-up time and use of quantitative methods
for assessing retinal vascular fractal dimensions by
standardised protocols. Furthermore, it was possible to adjust
for a broad spectrum of baseline variables, including vessel
diameter and the level of microvascular complications. Few
patients (n=5) had ungradable retinal photos and the remain-
ing were all graded by the same certified and validated grader.
Most participants had little or no vascular disease at baseline,
which allowed a good estimate of the predictive value of the
retinal fractal dimension to be made because progression to
the end stage of any complication is associated with a major
change in microvasculature.
A limitation is the relatively small number of participants
and the low number of incident cases; nonetheless, our results
were statistically significant. Intermediate measurements of
the cohort would provide valuable information on the timeline
of development of complications and correlating changes in
retinal vasculature, but such data were not available.
In conclusion, our study has shown the retinal vascular
fractal dimension to be a possible common preclinical biomark-
er of the three major complications seen in type 1 diabetes:
DPN, DN and PDR. This indicates that diabetic microvascular
Table 2 Associations between retinal vascular fractal dimensions and 16 year incidences of microvascular complications among 180 young patients
with type 1 diabetes from the DCPD1987 study
Model Change in fractal
dimension
DPN DN PDR
OR 95% CI p valuea OR 95% CI p valuea OR 95% CI p valuea
1 −0.01 1.16 1.04, 1,29 <0.01 1.24 1.10, 1.39 <0.01 1.18 1.10, 1.27 <0.01
2 −0.01 1.19 1.06, 1.33 <0.01 1.27 1.11, 1.45 <0.01 1.21 1.11, 1.31 <0.01
3 −0.01 1.16 1.02, 1.32 <0.03 1.28 1.09, 1.50 <0.01 1.23 1.11, 1.35 <0.01
4 −0.01 1.18 1.02, 1.36 <0.03 1.23 1.05, 1.44 <0.02 1.24 1.11, 1.39 <0.01
5 −0.01 1.17 1.01, 1.36 <0.05 1.40 1.10, 1.79 <0.01 1.22 1.09, 1.37 <0.01
Model 1: univariate logistic regression, using only the retinal vascular fractal dimension as a predictor
Model 2: multiple logistic regressions, adjusted for sex and baseline (1995) age and duration
Model 3: same as Model 2, with additional adjustments for baseline (1995) HbA1c, systolic and diastolic BP and BMI.
Model 4: model 3, with additional adjustments for baseline (1995) level of retinopathy, VPT and albuminuria
Model 5: model 4, with additional adjustments for CRAE and CRVE
aCalculated using logistic regression models
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complications share a common pathogenic pathway. Fractal
analysis is therefore a potentially useful non-invasive tool for
early risk stratification in diabetes regarding any microvascular
complication. Fractal analysis of the retinal vasculature has
previously demonstrated a high level of reproducibility [33];
however, the time to process each image needs to be shortened
before its clinical use can be considered.
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